US Patent Issued to MEDICOVESTOR on March 17 for "Oligomeric IgG for immunotherapeutics and diagnostics" (Delaware Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,321, issued on March 17, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).

"Oligomeric IgG for immunotherapeutics and diagnostics" was invented by Seah Lim (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to dimeric immunotherapeutics that comprise an IgG that is crosslinked with a disulfide bond. The IgG may include two heavy chains including a cysteine mutation that forms the disulfide bond. The dimeric immunotherapeutics are formed by increasing the concentration of the IgG such that spontaneous dimerization via the formation of disulfide bonds between the IgG molecules occurs over time."

The patent w...